Ep. 124: Jim Roppel: Liquidity, Cushion and 30 Years Of Studying Bill O’Neil
Investing With IBD
00:00
Dexcom's Relative Strength Is Up 40% in 2022
Dexcom is up 25% just from the top of the consolidation. It's got 11 weeks in a row up, not counting this week. Earnings next year in 2022 are supposed to be up 40%. Relative strength is not sky high because it's coming out of a huge base.
Transcript
Play full episode
